GE HealthCare Technologies (GEHC) Expected to Announce Earnings on Thursday

GE HealthCare Technologies (NASDAQ:GEHC) is expected to be issuing its quarterly earnings data before the market opens on Thursday, February 13th. Analysts expect the company to announce earnings of $1.26 per share and revenue of $5.33 billion for the quarter. Individual interested in listening to the company’s earnings conference call can do so using this link.

GE HealthCare Technologies Stock Performance

GEHC opened at $87.17 on Thursday. The firm has a market cap of $39.83 billion, a P/E ratio of 23.95, a price-to-earnings-growth ratio of 2.92 and a beta of 1.15. The business’s fifty day moving average is $83.14 and its 200-day moving average is $85.15. GE HealthCare Technologies has a 52-week low of $74.51 and a 52-week high of $94.55. The company has a debt-to-equity ratio of 1.12, a quick ratio of 0.98 and a current ratio of 1.23.

GE HealthCare Technologies Increases Dividend

The company also recently declared a quarterly dividend, which will be paid on Friday, February 14th. Investors of record on Tuesday, January 14th will be given a dividend of $0.035 per share. This is a positive change from GE HealthCare Technologies’s previous quarterly dividend of $0.03. The ex-dividend date of this dividend is Tuesday, January 14th. This represents a $0.14 annualized dividend and a dividend yield of 0.16%. GE HealthCare Technologies’s dividend payout ratio (DPR) is currently 3.85%.

Analyst Upgrades and Downgrades

A number of equities research analysts have recently weighed in on GEHC shares. Jefferies Financial Group upgraded shares of GE HealthCare Technologies from a “hold” rating to a “buy” rating and raised their price target for the company from $95.00 to $103.00 in a research note on Wednesday, January 8th. Wells Fargo & Company raised their target price on shares of GE HealthCare Technologies from $95.00 to $96.00 and gave the company an “overweight” rating in a research report on Thursday, October 31st. One analyst has rated the stock with a sell rating, four have assigned a hold rating, nine have issued a buy rating and one has issued a strong buy rating to the stock. Based on data from MarketBeat, the stock has an average rating of “Moderate Buy” and a consensus price target of $96.00.

About GE HealthCare Technologies

GE HealthCare Technologies Inc engages in the development, manufacture, and marketing of products, services, and complementary digital solutions used in the diagnosis, treatment, and monitoring of patients in the United States, Canada, and internationally. The company operates through four segments: Imaging, Ultrasound, Patient Care Solutions, and Pharmaceutical Diagnostics.